2 stories
AI briefings + tags; source links are the ground truth.
About
🇪🇸
Spain
El Mundo
National & Local
First battle of the 'Ozempic' pill: Lilly's tablet outperforms Novo Nordisk's
Lilly's anti-obesity pill, orforglipron, shows better results than Novo Nordisk's semaglutide in controlling blood sugar and weight for type 2 diabetes patients, despite higher discontinuation rates due to side effects.
Feb 28 • 00:05 UTC
🇬🇧
UK
Guardian
National & Local
New GLP1 pill helps patients lose up to 8% of body weight, trial shows
A new daily pill called orforglipron shows promise in helping patients lose weight, according to a clinical trial, potentially offering a non-injection alternative to existing GLP-1 medications.
Feb 26 • 11:39 UTC